Sort   by:  
 Page size 
MetabolomicsAbsence of tmRNA Increases the Persistence to Cefotaxime and the Intercellular Accumulation of Metabolite GlcNAc in Aeromonas veronii
Bacterial persisters are a small proportion of phenotypically heterogeneous variants with the transient capability to survive in high concentrations of antibiotics, causing recurrent infections in both human and aquatic animals. Transfer-messenger RNA (tmRNA), which was encoded by the ssrA ge...
2021-10-18 | MTBLS1182 | MetaboLights
UnknownDiscovery of a novel IL-15 based protein with improved developability and efficacy for cancer immunotherapy.
Not available
S-EPMC5955975 | biostudies-literature
UnknownDiscovery of Imidazoisoindole Derivatives as Highly Potent and Orally Active Indoleamine-2,3-dioxygenase Inhibitors.
Not available
S-EPMC6580535 | biostudies-literature
UnknownDiscovery of Hydroxyamidine Derivatives as Highly Potent, Selective Indoleamine-2,3-dioxygenase 1 Inhibitors.
Not available
S-EPMC7883375 | biostudies-literature
UnknownABA-inducible DEEPER ROOTING 1 improves adaptation of maize to water deficiency.
Not available
S-EPMC9616520 | biostudies-literature
UnknownDiscovery of SHR0687, a Highly Potent and Peripheral Nervous System-Restricted KOR Agonist.
Not available
S-EPMC7667827 | biostudies-literature
UnknownDiscovery of SHR1653, a Highly Potent and Selective OTR Antagonist with Improved Blood-Brain Barrier Penetration.
Not available
S-EPMC6580551 | biostudies-literature
UnknownDiscovery of SHR9352: A Highly Potent G Protein-Biased μ-Opioid Receptor Agonist.
Not available
S-EPMC6645658 | biostudies-literature
UnknownDiscovery of a novel RORγ antagonist with skin-restricted exposure for topical treatment of mild to moderate psoriasis.
Not available
S-EPMC8080595 | biostudies-literature
TranscriptomicsmiR-27b synergizes with anticancer drugs
Drug resistance, caused by complex and redundant mechanisms, is a major obstacle in cancer treatment, especially in liver and kidney cancers. Combinational therapy of miRNAs, which concurrently target multiple pathways, with anticancer drugs represent a new strategy to improve the drug response. By ...
ORGANISM(S): Homo sapiens 
2014-01-07 | E-GEOD-53872 | biostudies-arrayexpress
Sort   by:  
 Page size